Mona Al Mukaddam, M.D., M.S.

faculty photo
Associate Professor of Clinical Medicine
Department: Medicine
Contact information
3rd floor Penn Medicine University City
3737 Market Street
Philadelphia, PA 19104
Office: 215-662-9905
Email: mona.almukaddam@pennmedicine.upenn.edu
Links
Podcast on Women's Health in FOP
Global CME on treatment considerations in Fibrodysplasia Ossificans Progressiva (FOP)
Report on a patient with a rare bone disease correctly diagnosed at the Penn Bone Center
Remembering Carol Orzel, FOP patient, who donated her skeleton to the the mutter museum.
Penn Bone Center
Commentary regarding type 1 diabetes and bone in medpage today
Official website for International Clinical Council on Fibrodysplasia Ossificans Progressiva
CME titled "First Do No Harm: Realizing Timely Diagnosis and Treatment for Patients with Fibrodysplasia Ossificans Progressiva"
Penn bone Center featured in Penn Medicine Women's health newsletter
Interviewed for a Penn primary care podcast to discuss osteoporosis
CDC sponsored virtual grand round on evaluation and management of bone health in patients with Thalassemia https://www.cdc.gov/ncbddd/thalassemia/webinar-archives.html
Endocrinology Spotlight Series: Management of Calcium and Metabolic Bone Disorders Expert Guidance for Challenging Cases
Penn Primary Care Podcast discussing osteoporosis Hosted by Drs Amber Bird, Deepa Rani Nandiwada and Mona Al Mukaddam
Webinar on COVID-19 vaccinations in FOP patients
International Fibrodysplasia Ossificans Progressiva Association
Education:
BS
American University of Beirut, Lebanon, 2001.
 MD
American University of Beirut, Lebanon, 2005.
 MS
University of Pennsylvania, Institute of Translational Medicine and Therapeutics, 2013.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Metabolic bone and calcium disorders including osteoporosis, Paget's disease, hypo- and hyper-parathyroidism as well as bone diseases related to transplant, medications (example aromatase inhibitors and glucocorticoids) and iron overload.
Rare bone disease including Fibrodysplasia Ossificans Progressiva and hypophosphatasia.

Description of Research Expertise

Clinical research in Fibrodysplasia Ossificans Progressiva.
Evaluation of osteoporosis and the effects of treatment/diseases on "bone quality" using high resolution imaging of bone (uMRI).

Selected Publications

Jones, Brandon; Lee, Hyunyeol; Cheng, Cheng-Chieh; Al Mukaddam, Mona; Song, Hee Kwon; Snyder, Peter; Kamona, Nada; Rajapakse, Chamith; Wehrli, Felix: MRI Quantification of Cortical Bone Porosity, Mineralization, and Morphology in Postmenopausal Osteoporosis. Radiology Jan 2023 Notes: Accepted for publication in Nov 2022.

 Pignolo RJ, Hsiao EC, Al Mukaddam M, Baujat G, Berglund SK, Brown MA, Cheung AM, De Cunto C, Delai P, Haga N, Kannu P, Keen R, Le Quan Sang KH, Mancilla EE, Marino R, Strahs A, Kaplan FS: Reduction of New Heterotopic Ossification (HO) in the Open-Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP). J Bone Miner Res Dec 2022.

 Al Mukaddam M, Toder KS, Davis M, Cali A, Liljesthröm M, Hollywood S, Croskery K, Grandoulier AS, Böing EA, Whalen JD, Kaplan FS.: The impact of fibrodysplasia ossificans progressiva (FOP) on patients and their family members: results from an international burden of illness survey. Expert Rev Pharmacoecon Outcomes Res Dec 2022.

 Pignolo RJ, Baujat G, Brown MA, De Cunto C, Hsiao EC, Keen R, Al Mukaddam M, Le Quan Sang KH, Wilson A, Marino R, Strahs A, Kaplan FS: The natural history of fibrodysplasia ossificans progressiva: A prospective, global 36-month study. Genet Med Dec 2022.

 Mona Al Mukaddam, Katherine S. Toder, Michelle Davis, Amanda Cali, Moira Liljesthröm, Suzanne Hollywood, Kim Croskery, Anne-Sophie Grandoulier, Elaine A. Böing, Jan Swiderski, John D. Whalen, Frederick S. Kaplan : Using a Patient-Centric Approach to Understand the Impact of Fibrodysplasia Ossificans Progressiva (FOP) in an International Burden of Illness Survey. Oral Presentation at the FOP Drug Development Forum Nov 2022.

 Robert J. Pignolo, Edward C. Hsiao, Mona Al Mukaddam, Geneviève Baujat, Staffan K. Berglund, Matthew A. Brown, Angela M. Cheung, Carmen De Cunto, Patricia Delai, Nobuhiko Haga, Peter Kannu, Richard Keen, Kim-Hanh Le Quan Sang, Edna E. Mancilla, Rose Marino, Andrew Strahs, Frederick S. Kaplan : Reduction of New HO in the Open-Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva. Oral Presentation at the FOP Drug Development Forum Nov 2022.

 Mona Al Mukaddam, Katherine S. Toder, Michelle Davis, Kim Croskery, Anne-Sophie Grandoulier, Elaine A. Böing, Frederick S. Kaplan: Joint Function and Quality of Life in Fibrodysplasia Ossificans Progressiva: Results from an International Burden of Illness Survey of Patients and Family Members. Poster Presentation at ASBMR annual meeting Sept 2022.

 Robert J. Pignolo, Geneviève Baujat, Carmen De Cunto, Edward C. Hsiao, Richard Keen, Mona Al Mukaddam, Rose Marino, Elaine A. Böing, Anne-Sophie Grandoulier, Frederick S. Kaplan: Association of Heterotopic Ossification with Use of Aids, Assistive Devices, and Adaptations in Individuals with Fibrodysplasia Ossificans Progressiva. Poster Presentation at ASBMR annual meeting Sept 2022.

 Farzana A. Sayani, Ashutosh Lal, Gregory E. Tasian, Mona Al Mukaddam, David W. Killilea, Ellen B. Fung: Kidney Stones in Transfusion-Dependent Thalassemia: Prevalence and Risk Factors. Open Journal of Urology 12(4): 209-227, April 2022.

 Kaplan, F. S., Groppe, J. C., Xu, M., Towler, O. W., Grunvald, E., Kalunian, K., Kallish, S., Al Mukaddam, M., Pignolo, R. J., & Shore, E. M. : An ACVR1R375P pathogenic variant in two families with mild fibrodysplasia ossificans progressiva. American Journal of Medical Genetics Part A: 1-12, March 2022.
back to top
Last updated: 02/23/2023
The Trustees of the University of Pennsylvania
 
Back to Top